Rosalind Advisors »

Celldex Therapeutics shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $11M 330k 31.72